MétaCan
Menu
Back to cohort
Record W2587653683 · doi:10.1093/ecco-jcc/jjx002.619

P495 Intensified infliximab rescue therapy for acute severe ulcerative colitis does not improve long term colectomy-free survival

2017· article· en· W2587653683 on OpenAlexaffabout
Areen Khoury, C.-Y. Chao, Achuthan Aruljothy, Jonathan Wyse, Talat Bessissow

Bibliographic record

VenueJournal of Crohn s and Colitis · 2017
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsJewish General HospitalMcGill University Health CentreMcGill University
Fundersnot available
KeywordsMedicineInfliximabColectomyUlcerative colitisInternal medicineRegimenDosingCohortRetrospective cohort studyRefractory (planetary science)SurgeryMaintenance therapyGastroenterologyChemotherapy

Abstract

fetched live from OpenAlex

Background: Infliximab (IFX) is an effective rescue therapy for hospitalized steroid refractory acute ulcerative colitis (ASUC). Treatment response is associated with serum IFX trough levels. Intensified dosing regimens with escalated dose and/or shortened interval are increasingly used to compensate for the higher inflammatory burden and drug clearance. Our study aims to determine if intensified IFX induction regimen improves colectomy-free outcomes and identify predictors of long term outcomes. Methods: A retrospective review was performed between July 2010 and May 2016 at McGill University hospitals. All hospitalized adult patients who received at least one infusion of IFX as rescue therapy for steroid refractory ASUC were identified through our pharmacy drug database. We compared standard inductions with 5mg/kg vs 10mg/kg as well as shortened induction interval (i.e. completion of induction within 4 weeks). The primary outcome was the colectomy rate at 2 years. Baseline clinical parameters and dosing regimen were explored with regression analysis. Results: 72 patients (38% female, mean age 41) were identified. 37 patients (51%) received standard 5 mg/kg IFX induction and 35 received 10 mg/kg. 5 patients received shortened induction interval with IFX 10mg/kg. Baseline clinical parameters were well matched among various regimens. The 30-day and 2-year colectomy rate in our cohort was 6.9% and 15.2% respectively. 2-year colectomy-free survival was not significantly different between the standard (86.5%) and escalated (82.9%) dose IFX induction (p=0.388) whereas the shortened induction was associated with lower colectomy-free rate (40% versus standard induction 88.1%, p<0.001). Hemoglobin ≤90 g/L (OR 4.8 [95% CI: 1.2–19.1], p=0.03), albumin <30 g/L (OR 7.9 [95% CI: 1.5–40.1], p=0.01) and a short IFX induction regimen (OR 11.1 [95% CI: 1.6–76.6], p=0.015) were all associated with increased risk of colectomy at 2 years in univariate regression analysis. Albumin <30 g/L remained significant in multivariate modelling (p=0.03). Figure 1. Colectomy free survival. Infliximab 5 versus 10 mg/kg induction. Figure 2. Colectomy free survival. Short versus standard interval induction. Conclusions: Use of intensified infliximab rescue therapy did not improve 2-year colectomy-free survival in this cohort. Tailored use in high risk patients such as those with low albumin and hemoglobin may be beneficial although this needs to be validated in prospective clinical trials.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.004

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.011
GPT teacher head0.278
Teacher spread0.266 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2017
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Crohn s and ColitisSame topicInflammatory Bowel DiseaseFrench-language works237,207